Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. méd. Chile ; 130(4): 363-367, abr. 2002. graf
Article in Spanish | LILACS | ID: lil-314917

ABSTRACT

Background: Cellular immune mechanisms of the resistance to infection by T cruzi as well as the pathogenesis of Chagas disease are still controversial. Aim: To quantify and analyse the peripheral blood immune cells from chagasic and non chagasic patients by flow cytometry. Patients and methods: Peripheral blood samples were taken from 21 individuals seropositive for Chagas disease, under no specific treatment. Control samples from 21 healthy blood donors were also obtained. To quantify immune cells populations by flow cytometry, antibodies against CD3, CD4, CD8, CD16/56, CD45/14, CD19 and HLA-DR markers were used. Results: The percentage of CD8+ cells was low and the CD4+/CD8+ ratio was high in chagasic patients, compared to their non infected counterparts. No statistically significant differences in the number of CD4+, NK, B, CD4+HLADR+ and CD8+HLADR+ cells, were observed within the two groups. Conclusions: These results show that Chilean chronic chagasic patients have lower percentage of CD8+ cells and higher CD4+/CD8+ ratio than non infected individuals


Subject(s)
Humans , Male , Adult , Female , Middle Aged , Chagas Disease , Immunophenotyping/methods , Trypanosoma cruzi , CD4-Positive T-Lymphocytes , Case-Control Studies , Lymphocyte Count , CD8-Positive T-Lymphocytes , Flow Cytometry/methods
2.
Rev. méd. Chile ; 126(3): 265-70, mar. 1998. ilus, tab
Article in Spanish | LILACS | ID: lil-210573

ABSTRACT

Background: Chagas disease is endemic in Chile. Allopurinol and itraconazole have activity against Trypanosoma cruzi and are recommended for the treatment of chronic disease in adults. Aim: To evaluate the chemotherapeutic effects of allopurinol and itraconazole using conventional and non conventional serologic test. Patients and methods: Sera of 90 patients with chonic Chagas disease were studied before and after 9 to 11 months of treatment with allopurinol or itraconazole and after two month of treatment with placebo. Indirect immunofluorescence, ELISA and Western Blot analysis were the conventional serologic tests used and antibody dependent complement mediated lysis (CoML) the non conventional test. Results: There were no differences in ELISA and indirect immunofluorescence tests before and after therapy. Antigenic recognition profiles by Western Blot showed qualitative and quantitative differences in a small number of cases. CoML showed that the greater negativity was achieved in the Chagasic group treated with allopurinol or itraconazole that had a negative xenodiagnosis before drugs treatment (35.8 and 61.6 percent, respectively). Conclusions: There is a reversion of lytic activity in sera of patients with negative xenodiagnosis before treatment, suggesting the parasitemia could be an important parameter to be considered in the chemotherapy of Chagas disease


Subject(s)
Humans , Male , Female , Adolescent , Adult , Allopurinol , Chagas Disease/drug therapy , Itraconazole , In Vitro Techniques , Serologic Tests/methods , Placebos , Blotting, Western , Chagas Disease/blood , Fluorescent Antibody Technique, Indirect , Skin Tests/methods
SELECTION OF CITATIONS
SEARCH DETAIL